0.05Open0.05Pre Close0 Volume102 Open Interest2.50Strike Price0.00Turnover3555.98%IV24.15%PremiumAug 16, 2024Expiry Date0.00Intrinsic Value100Multiplier-1DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type-0.1179Delta0.2543Gamma64.60Leverage Ratio-4.5773Theta0.0000Rho-7.62Eff Leverage0.0000Vega
Macrogenics Stock Discussion
f@#$%^&* up
MacroGenics Announces Achievement of $100 Million in Milestones Related to Retifanlimab Collaboration With Incyte
MacroGenics Announces Achievement of $100 Million in Milestones Related to Retifanlimab Collaboration with Incyte
No comment yet